Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx

PURPOSE: Cancer-related cognitive impairment (CRCI) is common during adjuvant chemotherapy and may persist. TAILORx provided a novel opportunity to prospectively assess patient-reported cognitive impairment among women with early breast cancer who were randomly assigned to chemoendocrine therapy (CT...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Wagner, Lynne I., Gray, Robert J., Sparano, Joseph A., Whelan, Timothy J., Garcia, Sofia F., Yanez, Betina, Tevaarwerk, Amye J., Carlos, Ruth C., Albain, Kathy S., Olson, John A., Goetz, Matthew P., Pritchard, Kathleen I., Hayes, Daniel F., Geyer, Charles E., Dees, E. Claire, McCaskill-Stevens, Worta J., Minasian, Lori M., Sledge, George W., Cella, David
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2020
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7280048/
https://ncbi.nlm.nih.gov/pubmed/32271671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01866
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars